Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

US Patent 11279703 · Granted Mar 22, 2022

Estimated economic value: $2,836,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Chemical compounds2023
Anti-infective heterocyclic compounds and uses thereof2021
Anti-infective heterocyclic compounds and uses thereof2021
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2021
Chemical compounds2020
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2020
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2019
Substituted pyrimidine compounds, compositions and medicinal applications thereo2019
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2018
Pyridine derivatives2017
Pyridine derivatives2016